TPTX - Turning Point Therapeutics EPS misses by $0.12 beats on revenue May, 05 2021 04:31 PM Turning Point Therapeutics Inc. Turning Point Therapeutics (TPTX): Q1 GAAP EPS of -$0.73 misses by $0.12.Revenue of $25.2M beats by $7.7M.Press Release For further details see: Turning Point Therapeutics EPS misses by $0.12, beats on revenue